1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow Diagnosis: new trials by email Literature Review of Diagnosis trials Research Report on Diagnosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia Gilteritinib - Acute Myeloid Leukemia, FLT3 Gene Mutation | Phase 2 | Not yet recruiting | Gruppo Italiano Malattie EMatologiche dell'Adulto | 80 | 2025-06-01 | 2025-03-12 |
| Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers MetriDx - Endometriosis, Diagnosis | Phase 2 | Recruiting | Hera Biotech, Inc. | 75 | 2022-09-14 | 2023-01-26 |
| Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis. iron fumarate - Hemochromatosis, Type 4, Ferroportin Disease | Phase 2 | Completed | Rennes University Hospital | 62 | 2014-02-10 | 2019-03-27 |
Disease (3) · Endometriosis (1) · Hemochromatosis (1) · Hemochromatosis, type 4 (1) · Hyperferritinemia (1) · Leukemia, Myeloid, Acute (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Iron Metabolism Disorders (1) · Iron Overload (1) · Leukemia (1) · Leukemia, Myeloid (1) · Metabolic Diseases (1)
gilteritinib (1)
Gruppo Italiano Malattie EMatologiche dell'Adulto (1) · Hera Biotech, Inc. (1) · Rennes University Hospital (1)
France (1) · United States (1)
Charles R Kirkham, MD (1) · Fabio Guolo (1) · Jacqueline A Robinson, MD (1) · Sandra M Hurtado, MD (1)